Skip to main content

Find Clinical Trials

Home
Conditions
Herpes Zoster

Clinical trial condition

Herpes Zoster

Explore clinical trials studying Herpes Zoster. Study availability and eligibility vary by location and protocol.

175 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Herpes Zoster trial results

Completed

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)

NCT01229267

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)

NCT01254630

Conditions: DNA Virus Infections, Hematologic Diseases, Hematologic Neoplasms, +8 more
Locations: Not specified

View Trial Details

Completed

Burden of Herpes Zoster and Post-herpetic Neuralgia Among People ≥ 50 Years Old in France

NCT02487472

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +12 more
Locations: Not specified

View Trial Details

Completed

Enhancing a Sustainable Pharmacy-based Immunization Program in Two States

NCT02615470

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, DNA Virus Infections, +8 more
Locations: Auburn University Auburn, Alabama, United States

Keck Graduate Institute School of Pharmacy Claremont, California, United States

View Trial Details

Completed

Month 30 & 42 Extension Studies of CRD-004 Primary Study

NCT00492648

Conditions: Chickenpox, DNA Virus Infections, Herpes Zoster, +4 more
Locations: GSK Investigational Site Ghent, Belgium

View Trial Details

Completed

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years

NCT00802464

Conditions: Chickenpox, DNA Virus Infections, Herpes Zoster, +4 more
Locations: GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Pembroke Pines, Florida, United States

GSK Investigational Site Las Vegas, Nevada, United States

GSK Investigational Site Edison, New Jersey, United States

View Trial Details

Completed

Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster

NCT03553472

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +13 more
Locations: University of Wisconsin Digestive Health Center Madison, Wisconsin, United States

View Trial Details

Completed

A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002)

NCT00535236

Conditions: DNA Virus Infections, Herpes Zoster, Herpes Zoster-related Complications, +4 more
Locations: Not specified

View Trial Details

Completed

Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo

NCT02902822

Conditions: Actinic Keratosis, Alzheimer Disease, Bacterial Infections, +56 more
Locations: Local Health Authority (ATS) Bergamo, Italy

View Trial Details

Completed

Efficacy of Oral Famciclovir Versus Aciclovir Treatment in Patients With Herpes Zoster

NCT01327144

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: Centro de Medicina Reprodutiva Dr Carlos Isaia Filho Porto Alegre, Rio Grande do Sul, Brazil

Loema Campinas, São Paulo, Brazil

Allergisa Campinas, São Paulo, Brazil

CECIP Centro de Estudos Clínicos do Interior Paulista Jaú, São Paulo, Brazil

View Trial Details